Categories: Tech

Clarivate Partners with CRKN to Further Canada’s Research Goals

Web of Science Provides Expanded Access to Essential Research Tools and Data for Canadian Libraries and Research Institutions

- Advertisement -

LONDON, June 3, 2025 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a multi-year partnership with the Canadian Research Knowledge Network (CRKN), a consortium of libraries and research institutions in Canada. The agreement provides 55 Canadian universities with expanded access to the Web of Science and is designed to enhance inter-member research collaborations, improving accessibility to Web of Science content for all members.

- Advertisement -

The Web of Science platform is home to the world’s first and most trusted publisher-neutral citation index – Web of Science Core Collection – and connects developments along the entire research lifecycle to that trustworthy core. It streamlines the discovery of content from the world’s leading journals alongside conference papers, books, dissertations and theses, datasets, patents, preprints, awarded grants, policy documents and more.  

- Advertisement -

For CRKN members, new extended access to the Web of Science API will allow researchers to use the rich Web of Science metadata to support their research projects. Access to the Derwent Innovations Index and the Policy Citation Index will help members better understand the societal impact of their outputs.

- Advertisement -

Craig Olsvik, Director, Content Program at CRKN, said: “CRKN is pleased to have renewed our agreement with Clarivate for Web of Science through 2029. Expanded access to Web of Science content will serve Canadian researchers across the country, and we’re particularly happy to now include extended access to the Web of Science API for our members.”

- Advertisement -

Bar Veinstein, President of Academia and Government at Clarivate, said: “We are delighted to extend our partnership with CKRN. Canada holds a prominent and often collaborative position in academic research globally, with its research contributions surpassing the international average in terms of innovation and patents.

- Advertisement -

“This new agreement underscores the value we offer to Canadian institutions and researchers through the Web of Science. We remain committed to supporting the research community in Canada by providing the necessary tools and resources to foster innovation and discovery which ultimately drives societal impact.”

- Advertisement -

About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com 

- Advertisement -

Media contact:
Rebecca Krahenbuhl, Senior Manager, External Communications, Academia & Government
newsroom@clarivate.com  

- Advertisement -

Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo_v1.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-partners-with-crkn-to-further-canadas-research-goals-302471426.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

1 week ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago